Q32 Bio INC S-1 registration statements

Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.

NASDAQ
Q32 Bio Inc. is registering for resale up to 1,682,045 shares of its common stock by selling stockholders after completing its merger with Homology Medicines.